Delivery of a gene-editing system with a single retroviral particle and methods of generation and use
AssigneeRegeneron Pharmaceuticals, Inc.
InventorsChristos Kyratsous, Andrew J. Murphy, Cheng Wang
Life of this patent
Estimating the term…
Loading patent…
AssigneeRegeneron Pharmaceuticals, Inc.
InventorsChristos Kyratsous, Andrew J. Murphy, Cheng Wang
Estimating the term…
The invention provides a recombinant RNA molecule comprising (i) a sequence of a gene-editing molecule mRNA, or a sequence of a functional fragment or derivative thereof, and (ii) at least one sequence of a coding or non-coding enrichment RNA, or a sequence of a functional fragment or derivative thereof, wherein the enrichment RNA, or functional fragment or derivative thereof, is capable of enhancing inclusion of the gene-editing molecule mRNA, or functional fragment or derivative thereof, into a retroviral particle. The invention provides a method of producing the retroviral particles of the invention, the method comprising culturing a packaging cell in conditions sufficient for the production of a plurality of retroviral particles.
A recombinant RNA molecule comprising (i) a sequence of a gene-editing molecule mRNA, or a sequence of a functional fragment thereof, and (ii) a sequence of a non-coding enrichment RNA, wherein said non-coding enrichment RNA comprises 7SL RNA, or a functional fragment thereof, and is capable of enhancing inclusion of said gene-editing molecule mRNA, or functional fragment thereof, into a retroviral particle.
Dependencies are inferred from the claim text.